NewsRoom Articles - Page 1083 of 1389

TuesdayMar 13, 2018 2:30 pm

OTC Markets Group, Inc. (OTCM) Starts Presentation at 30th Annual ROTH Conference

OTC Markets Group (OTC: OTCM) operates financial markets for 10,000 U.S. and global securities, including the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market. Through OTC Link® ATS, a varied network is connected, comprised of broker-dealers that offer liquidity and execution services. OTC Markets Group enables investors to trade easily through the broker of their choice and empowers companies to enhance the quality of information available to investors. OTC Market Group offers services in three central areas: trading services, market data and corporate services. For more information, visit the company’s website at www.otcmarkets.com. About NetworkNewsWire NetworkNewsWire…

TuesdayMar 13, 2018 2:30 pm

KemPharm, Inc. (NASDAQ: KMPH) Starts Presentation at 30th Annual ROTH Conference

KemPharm (NASDAQ: KMPH) is a clinical-stage specialty pharmaceutical company that discovers and develops new proprietary prodrugs in the United States through its proprietary Ligand Activated Therapy (“LATTM”) platform technology. KemPharm’s co-lead clinical development candidates are KP415 and KP484, both based on a prodrug of methylphenidate, but with differing extended-release and effect profiles for the treatment of ADHD. Apadaz™, the company’s product candidate of benzhydrocodone, a prodrug of hydrocodone and acetaminophen, has received FDA approval. The company is also involved in developing KP201/IR (APAP-free), an IR formulation of KP201 without APAP for the short-term management of acute pain. For more information,…

TuesdayMar 13, 2018 2:30 pm

Hexindai, Inc. (NASDAQ: HX) Starts Presentation at 30th Annual ROTH Conference

Hexindai (NASDAQ: HX), through its subsidiaries, operates an online consumer lending marketplace connecting borrowers and investors in the People's Republic of China. The company facilitates loans to meet the growing consumption demand of the emergent middle class in China. Hexindai provides borrowers convenient and ready access to credit and a wide range of products designed based on customer segmentation data and tailored to the specific needs of the evolving middle class in China. Hexindai offers investors various types of investment products with appropriate risk levels and risk-adjusted returns. For more information, visit the company’s website at http://ir.hexindai.com. About NetworkNewsWire NetworkNewsWire…

TuesdayMar 13, 2018 2:00 pm

Revolution Lighting Technologies, Inc. (NASDAQ: RVLT) Starts Presentation at 30th Annual ROTH Conference

Revolution Lighting Technologies (NASDAQ: RVLT) designs, manufactures and sells advanced LED lighting solutions, with a focus on the industrial, commercial and government markets in the United States, Canada and internationally. Through its cutting-edge LED technologies, Revolution Lighting has developed a pioneering lighting company that provides a comprehensive advanced product platform of top-quality interior and exterior LED lamps and fixtures. These products include signage and control systems. The company is uniquely positioned to serve as an expert partner, delivering full-service lighting solutions through its operating divisions and turning lighting into a source of outstanding energy savings, quality light and well-being. For…

TuesdayMar 13, 2018 2:00 pm

Ichor Holdings, Ltd. (NASDAQ: ICHR) Starts Presentation at 30th Annual ROTH Conference

Ichor Holdings (NASDAQ: ICHR) engages in the design, engineering and manufacturing of critical fluid delivery subsystems for semiconductor capital equipment. Ichor’s primary offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures certain components for internal use in fluid delivery systems and for direct sales. This vertically integrated portion of the company’s business is primarily focused on metal and plastic parts that are used in gas and chemical systems, respectively. For more information, visit the company’s website at…

TuesdayMar 13, 2018 2:00 pm

Insperity, Inc. (NYSE: NSP) Starts Presentation at 30th Annual ROTH Conference

Insperity (NYSE: NSP) provides an array of human resources and business solutions designed to help improve business performance. Insperity® Business Performance Advisors offers a comprehensive suite of products and services. The company delivers administrative relief, better benefits, reduced liabilities and a systematic way to improve productivity through its premier Workforce Optimization® solution. The company also offers human capital management, payroll software, time and attendance, performance management, organizational planning, recruiting services, employment screening, financial services, expense management, retirement services and insurance services. Insperity business performance solutions support more than 100,000 businesses with over 2 million employees in 68 offices throughout the…

TuesdayMar 13, 2018 2:00 pm

Health Insurance Innovations, Inc. (NASDAQ: HIIQ) Starts Presentation at 30th Annual ROTH Conference

Health Insurance Innovations (NASDAQ: HIIQ) is a distributor and cloud-based administrator of innovative, affordable health insurance products that meet the needs of health insurance plan shoppers. Through its relationships with best-in-class insurance companies, HIIQ develops insurance products and markets them through its broad distribution network of licensed insurance agents across the nation, its call center network and its unique online capability. The company’s consumer division includes AgileHealthInsurance.com, a website for researching, comparing and purchasing short-term health insurance products online and HealthPocket.com, a free website that compares and ranks all health insurance plans, and uses objective data to publish unbiased health…

TuesdayMar 13, 2018 2:00 pm

Can-Fite BioPharma Ltd. (NYSE: CANF) Starts Presentation at 30th Annual ROTH Conference

Can-Fite BioPharma (NYSE: CANF) is an advanced clinical stage drug development company with a platform technology that is intended to address multi-billion-dollar markets in the treatment of cancer, inflammatory disease and sexual dysfunction. Piclidenoson, Can-Fite's lead drug candidate, is currently in a phase 3 trial for rheumatoid arthritis and is expected to enter a phase 3 trial for psoriasis during 2018. The company’s liver cancer drug, Namodenoson, is in phase 2 trials for the most common form of liver cancer, hepatocellular carcinoma (“HCC”), and for the treatment of non-alcoholic steatohepatitis (“NASH”). Namodenoson has been granted Orphan Drug Designation in the…

TuesdayMar 13, 2018 2:00 pm

The Joint Corp. (NASDAQ: JYNT) Starts Presentation at 30th Annual ROTH Conference

The Joint (NASDAQ: JYNT) is a national operator, manager and franchisor of chiropractic clinics. An emerging growth company, The Joint is reinventing chiropractic by making it convenient and affordable for patients who are seeking pain relief and ongoing wellness to obtain quality care. The company has a no-appointment policy along with convenient hours and locations to make care more accessible, and The Joint also offers affordable membership plans and packages that eradicate the need for insurance. The Joint has almost 400 clinics throughout the United States and more than 4 million patient visits annually. For more information, visit the company’s…

TuesdayMar 13, 2018 2:00 pm

IRIDEX Corp. (NASDAQ: IRIX) Starts Presentation at 30th Annual ROTH Conference

IRIDEX (NASDAQ: IRIX) develops, manufactures and markets innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The company maintains a deep commitment to the success of its customers, with comprehensive technical, clinical, and service support programs. The company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. IRIDEX’s current product line is used for the treatment of glaucoma, diabetic macular edema and other retinal diseases. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

OTC Markets Group, Inc. (OTCM) Starts Presentation at 30th Annual ROTH Conference

KemPharm, Inc. (NASDAQ: KMPH) Starts Presentation at 30th Annual ROTH Conference

Hexindai, Inc. (NASDAQ: HX) Starts Presentation at 30th Annual ROTH Conference

Revolution Lighting Technologies, Inc. (NASDAQ: RVLT) Starts Presentation at 30th Annual ROTH Conference

Ichor Holdings, Ltd. (NASDAQ: ICHR) Starts Presentation at 30th Annual ROTH Conference

Insperity, Inc. (NYSE: NSP) Starts Presentation at 30th Annual ROTH Conference

Health Insurance Innovations, Inc. (NASDAQ: HIIQ) Starts Presentation at 30th Annual ROTH Conference

Can-Fite BioPharma Ltd. (NYSE: CANF) Starts Presentation at 30th Annual ROTH Conference

The Joint Corp. (NASDAQ: JYNT) Starts Presentation at 30th Annual ROTH Conference

IRIDEX Corp. (NASDAQ: IRIX) Starts Presentation at 30th Annual ROTH Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search